- Published at
- by manilatimes.net
mixed
mixed
News for LungLife AI, Inc. (LLAI.L)
- Published at
- by manilatimes.net
mixedmixed- Published at
- by globenewswire.com
mixedmixedLiquid Biopsy Market to Reach $ 32.54 Billion, Globally, by 2033 at 11.61% CAGR: The Brainy Insights
Advancement in next-generation sequencing (NGS) for patients with advanced stages of cancer is propelling liquid biopsy market growth. North America...- Published at
- by marketscreener.com
mixedmixedCindrigo seeks Croatian exploration licence extension
The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: ---------- Panther Metals PLC - Canada-focused mineral exploration...- Published at
- by globenewswire.com
negativenegativeCirculating Tumor Cells Market Projected to Exceed US$ 81.6
Marketresearch.biz reports that circulating tumor cells (CTCs) provide early warnings, enabling timely intervention and potentially improving patient...- Published at
- by marketscreener.com
mixedmixedAIM WINNERS & LOSERS: LungLife AI soars on test; Plexus falls on deal -January 02, 2024 at 05:06 am EST
The following stocks are the leading risers and fallers on AIM in London on Tuesday. ---------- AIM - WINNERS ---------- LungLife AI Inc, up 36% at 62.33 pence, 12-month range 19.00p-141.10p. The...- Published at
- by marketscreener.com
neutralneutralLungLife AI LungLB clinical validation study completion delayed
LungLife AI Inc on Thursday said it expects to conclude its clinical validation study for its LungLB test by the end of the fourth quarter of the year. The California-based developer of clinical...- Published at
- by prnewswire.com
mixedmixedPrecision Medicine Takes Center Stage: Innovative Report Explores the Role of Companion Diagnostics in Transforming Healthcare
/PRNewswire/ -- The "Companion Diagnostic Markets - the Future of Diagnostics by Application, Technology and Funding With Executive and Consultant Guides...- Published at
- by globenewswire.com
mixedmixed8.2% CAGR for Lung Cancer Screening Market Worth $4.36Bn by 2030 with NSCLC Segment (8% CAGR) Driving Growth During 2022-2030 | The Insight Partners
By technology, the LDCT segment will account maximum share in lung cancer screening market during 2022-2030. The lung cancer screening industry majorly...- Published at
- by prnewswire.com
mixedmixedLiquid Biopsy Market size is set to grow by USD 1.74 billion from 2021 to 2026|Increasing incidence of cancer is one of the key drivers - Technavio
/PRNewswire/ -- The liquid biopsy market size is estimated to grow by USD 1.74 billion from 2021 to 2026, according to Technavio. The market is estimated to...- Published at
- by marketscreener.com
neutralneutralLungLife celebrates as it completes enrolment for LungLB test study
LungLife AI Inc on Tuesday said that it has completed enrolment for its prospective validation study of LungLB. LungLife is a California-based developer of clinical diagnostic solutions designed to... | May 23, 2023- Published at
- by globenewswire.com
mixedmixedCirculating Tumor Cell (CTC) Diagnostics Market Size (2022-2030) Share, Industry Trends, Growth, Challenges and Forecast : Growth Plus Reports
Newark, New Castle, USA, March 22, 2023 (GLOBE NEWSWIRE) -- The global circulating tumor cell (CTC) diagnostics market will be valued at US$ 23.85...- Published at
- by marketscreener.com
mixedmixedSUMMARY: London listings with exposure to Silicon Valley Bank
The following is a round-up of updates on exposure to Silicon Valley Bank by London-listed companies, issued on Monday and not separately reported by Alliance News: ---------- FTSE... | March 13, 2023- Published at
- by marketscreener.com
mixedmixedPortfolio Update
Octopus AIM VCT plc Portfolio Update The investment portfolio of Octopus AIM VCT plc as at 21 September 2022 is as follows : Investee CompanySectorBook cost Movement in valuation Fair Value... | September 21, 2022VTU.LVTMTFVRCI.LVLS.LVEL.LTWDLFTWD.LTPG.LTAST.LSTAF.LSPA.LSOS.LSMD.LRWS.LRST.LRDT.LQXT.LPOLX.LPLLWFPHYOFPCIP.LOXFCFOSI.LNXFNFNTQ.LNFC.LMYX.LMXCT.LMXCL.LMER.LMAXCLTTHFLTG.LLLAI.LJDG.LIXI.LITS.LILIKFIKA.LGHH.LGDR.LGAMCFGAMA.LFLX.LFDBK.LFAB.LERGO.LEKF.LEKDHFDXRX.LDIUXFCRWRFCRW.LCOG.LBREE.LANCR.LADT.LACC.L2EM.DEVRE.LSDIIFSDI.LOOA.LNET.LMTW.LMED.LLUPGFLOOP.LIUG.LIDOX.LGBGPFGBG.LG4M.LDPP.LBRK.LAMS.LABDX.LTIDE.LRNUGFRENE.LPXAMFMSYS.LLSAI.LHDGHFHAYD.LEVG.L- Published at
- by globenewswire.com
mixedmixedPortfolio Update
Octopus AIM VCT 2 plc 18 August 2021 Portfolio Update The investment portfolio of Octopus AIM VCT 2 plc (the "Company") as at 18 August 2021 is as...WANSFWAND.LVTU.LVTMTFVRE.LVRCI.LVEGPFVEC.LTWDLFTWD.LTAST.LSYGGFSOS.LSNG.LSDIIFSDI.LRWS.LRST.LRNUGFRENE.LQXT.LPXAMFPOLX.LPLLWFPHYOFPCIP.LOSEC.LOOA.LNXFNFNFC.LNET.LMXCT.LMXCL.LMTPH.LMTPMSYS.LMER.LMED.LMEAL.LMAXCLUPGFLTTHFLTG.LLSAI.LLOOP.LLLAI.LJDG.LIXI.LIUG.LITS.LILIKFIKA.LIDOX.LGHH.LGBGPFGBG.LGAMCFGAMA.LG4M.LFLX.LFAB.LEVG.LERGO.LEKF.LDXRX.LDNL.LDIUXFCRWRFCRW.LCOG.LCLLLFCLIN.LCLIGFCALL.LBRK.LBREE.LANCR.LAMS.LADT.L2EM.DEVEL.LTPG.LTIDE.LSPA.LRDT.LOSI.LNTQ.LMTW.LMNO.LKRM.LHDGHFHAYD.LGDR.LFDBK.LESC.LDPP.LACC.LABDX.L